Pentagon temporarily rescinds guidance on testosterone screening for US troops
WASHINGTON — The Pentagon is temporarily rescinding recently published clinical guidance for a new, mandatory testosterone deficiency screening policy for service members aged 30 and older, a U.S. official told Reuters on Thursday. On Wednesday, the Pentagon posted the "Clinical Guidance for Health and Human Performance Optimization" on its website. By Thursday, the memo and an accompanying…
The Pentagon has temporarily withdrawn recently released clinical advice regarding mandatory testing for testosterone deficiency in U.S. military personnel aged 30 and above, according to a U.S. official quoted by Reuters on Thursday. The memo, which was initially posted on Wednesday, was removed from the Pentagon's website by Thursday.
The draft guidance, published on September 2, 2026, had been temporarily rescinded to permit revisions, according to the official. The interim guidance continues to be applicable. The comprehensive clinical guidelines outlined distinct pathways for testosterone deficiency screenings for both male and female service members, to be carried out during their routine annual health assessments.
The directive was set to commence immediately, with the Pentagon stating its objective was to enhance military readiness by identifying and managing hormonal and energy-related concerns.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
